Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.

Zheng, Jie, Haberland, Valeriia, Baird, Denis, Walker, Venexia, Haycock, Philip, Hurle, Mark, Gutteridge, Alex, Erola, Pau +26 more·2019·Nature Genetics

DOI 10.1101/627398

Cited by (834)

Items 501–600 of 834

Mendelian randomization reveals plasminogen as a common therapeutic target for myocardial infarction and atrial fibrillation
Hadi Charati, Ahmad Hamta‌ · 2024 · Journal of Cardiovascular and Thoracic Research
Identification of Potential Therapeutic Targets for Sensorineural Hearing Loss and Evaluation of Drug Development Potential Using Mendelian Randomization Analysis
Shun Ding, Qiling Tong, Yixuan Liu, Mengyao Qin, Shan Sun · 2025 · Bioengineering
NEK4: prediction of available drug targets and common genetic linkages in bipolar disorder and major depressive disorder
Bin Gong, Chenxu Xiao, Yu Feng, Jing Shen · 2025 · Frontiers in Psychiatry
A multi-omics target study for glioblastoma multiforme (GBM) based on Mendelian randomization analysis
Hao Sun, Xiangyin Liu, Jun Lu, Hao Fan, D. Lu, Haohan Sun, Zi-jian Zhou, Yuming Li, Xianyong Yin, Yuwen Song et al. · 2025 · IBRO Neuroscience Reports
Proteome-wide Mendelian randomization reveals causal associations between plasma proteins and autoimmune thyroid disease
Yang Li, Weixi Zhu, Yijing Chen, Qingqing Kang, Ying Zhang, Shumin Wang, Shumin Wang, Chao Liu, Qiu Zhang, Qiu Zhang · 2025 · Scientific Reports
Associations of 2923 plasma proteins with incident atopic dermatitis in a prospective cohort study and genetic analysis
Sui Deng, Miaoyi Zhang, Tongtong Zhang, Rui Mao · 2025 · Medicine
Two Birds With One Stone: The Protective Role of the Antidiabetic Drug Sodium‐Glucose Cotransporter‐2 Inhibitor in Neurodegenerative Diseases
Lirong Zhang, Liangchun Cai, Huiting Lin, Wenhua Wu, Lina Zhu, Jiaqin Cai, Congting Hu, Xinmiao Lin, Hong Sun, Xiaoxia Wei · 2025 · European Journal of Neuroscience
Revisiting the Links Between Asthma and the Psychosis Spectrum: Shared Molecular Mechanisms
Christina Dardani, Jamie W. Robinson, Alexandra Havdahl, Liza Darrous, Hannah J Jones, Stanley Zammit, Sarah A. Sullivan, Dheeraj Rai, Evie Stergiakouli, Zhaozhong Zhu et al. · 2026 · Biological Psychiatry
Single-cell and spatial transcriptomics identify dihydrolipoic acid succinyltransferase as a promoter of tumor invasion via vascular pathways in cutaneous melanoma
Jinghua Gu, Xinyu Cheng, Jiansheng Xu, Huake Cao, Pei Liu, Zihao Wang, Pengcheng Wu, Xu Dong Zhang, Rick Francis Thorne, Hua Wang et al. · 2025 · International Journal of Biological Macromolecules
Decoding NMDAR encephalitis: proteomic markers and computational identification of potential therapeutic pathways
Shengnan Wang, Yuhao Yuan, Xiaoqing Guo, Mengting Qin, Jiaojiao Chen, Dailiang Jiang, Yuhang Feng, Ling Mao · 2025 · Brain Behavior and Immunity
Revealing potential drug targets in liver dysfunction through proteome-wide Mendelian randomization
Xinmei Zhang, Tao Yang, Yingxin Zeng, Xin Yang, Huiting Rao, Nan Hu, Guo-Dong Xia · 2025 · Medicine
Development of targeted drugs for diabetic retinopathy using Mendelian randomized pharmacogenomics
Guodan Liu, Miao Tian, Xinge Li, Xichen Wang, Songhao Zhang, Gali Bai, Xuyang Zhang · 2025 · Frontiers in Endocrinology
Causal relationship between interleukin-6 levels and the risk of synovitis and tenosynovitis: A two-sample Mendelian randomization study
Bo Wang, Zongyang Li, Rui Zhou, Jianye Chen, Mingda Liu, Li Zhang · 2025 · Medicine
PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics
Huimin Guo, Guiwen Zheng, Shuzhan Yao, Qiang Jia, Jian Tan, Zhaowei Meng · 2025 · Neuroendocrinology
Toward real clinical utility: leveraging comprehensive cancer proteomic datasets for clinical insight
Karin Rodland, Bing Zhang · 2025 · Expert Review of Proteomics
Mendelian Randomization Suggests a Causal Link Between Glycemic Traits and Thoracic Aortic Structures and Diseases
Tselmen Daria, Kruthika Raman Iyer, Hasan Alkhairo, Pik Fang Kho, Suzuki Ken, Konstantinos Hatzikotoulas, Lorraine Southam, Henry J. Taylor, Xianyong Yin, Ravi Mandla et al. · 2025 · JACC Basic to Translational Science
Protein and gene levels of DNAJC21 and RNF5 as drug targets for immune thrombocytopenia: optimized post-GWAS insights
Xiaoli Li, Jun Li, Yang Lan, Yang Wan, Wenyu Yang, Xiaofan Zhu · 2025 · Hematology
Potential Drug Targets for Migraine Identified Through Mendelian Randomization Analysis of the Human Plasma Proteome
Longxin Guo, Jian Li, Zhe Chen, Xinyue Zhang, Chengxian Li · 2025 · Molecular Neurobiology
Leveraging large-scale biobanks for therapeutic target discovery
Brian R. Ferolito, Hesam Dashti, Claudia Giambartolomei, Gina Marie Peloso, Daniel J Golden, Kai Gravel-Pucillo, Danielle Rasooly, Andréa R. V. R. Horimoto, Rachael Matty, Liam Gaziano et al. · 2025 · Human Genetics and Genomics Advances
Novel common target genes for breast cancer and colorectal cancer: a Mendelian randomization and spatial transcriptomics study
Pengyu Miao, Zhaokai Zhou, Ling Zhang, Xufeng Huang, Zhengrui Li, Shouxin Wei, András Hajdú · 2025 · Discover Oncology
Deciphering tissue-specific protein regulation for insights into cardiometabolic disease
April E. Hartley, Katyayani Sukhavasi, Sile Hu, Matthew Traylor, Mar González-Ramírez, Kristian Hanghøj, Husain Ahammad Talukdar, Arno Ruusalepp, Ellen Björkegren, Johan Björkegren et al. · 2025 · Molecular Metabolism
Potential Risk Factors and Therapeutic Targets for Dilated Cardiomyopathy Identified Through Mendelian Randomization Analysis
Hui Wang, Yihui Wang, Dezhi Huang, Xiao Jiang, Caiyun Li, Xuting Xia, Guichun Liu, Jianchen Shi, Xinhui Li · 2025 · Journal of the American Heart Association
Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors
Jia-Jia Liu, Zhihe Chen, Qian Yang, Hong Lin, Shuang-Yuan Wang, Mian Li, Tian-Ge Wang, Zhi-Yun Zhao, Min Xu, Yu-Hong Chen et al. · 2026 · Communications Medicine
Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues
Ozvan Bocher, Ana Luiza Arruda, Satoshi Yoshiji, Chi Zhao, Alicia Huerta‐Chagoya, Chen‐Yang Su, Xianyong Yin, Davis Cammann, Henry J. Taylor, Jingchun Chen et al. · 2026 · Nature Metabolism
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease
Émilie Gobeil, Jérôme Bourgault, Éloi Gagnon, Nolwenn Samson, Louis‐Jacques Ruel, Valérie Côté, Patricia L. Mitchell, Clarisse Gotti, Florence Roux‐Dalvai, Arnaud Droit et al. · 2026 · The Journal of Clinical Endocrinology & Metabolism
Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry
Susannah Selber‐Hnatiw, Katerina Trajanoska, Justin Pelletier, Chen‐Yang Su, Peyton McClelland, Daniel Taliun, Satoshi Yoshiji, Vincent Mooser, Claude Bhérer, Sirui Zhou · 2026 · Circulation Genomic and Precision Medicine
Causal association between glucagon-like peptide-1 receptor agonists and mental disorders: insight from genetic and real-world evidence
Chenhao Ouyang, Xiaoyue Zhang, Minhai Zhang, Miao Yan, Zicheng Zhu, Yunting Zeng, Hong Ban, Yuting Wu, Nanqin Peng, Jitao Ling et al. · 2026 · Journal of Affective Disorders
Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic–proteomic–clinical study
Hang Zhou, Zihao Wang, Zixin Tan, Bin Deng, Wanlin Yang, Z Huang, Xingfang Guo, Jiaqi Li, Xinhao Wang, Yinghua Yu et al. · 2026 · EBioMedicine
Integrative mendelian randomization approaches for therapeutic target prioritisation in immune-mediated diseases
Maria K. Sobczyk, Tom R. Gaunt · 2026 · Scientific Reports
Subtype-Specific Causal Effects of Antidiabetic Drug Targets on Ovarian Cancer: Mendelian Randomization and Colocalization Evidence
Enyu Tang, Jia Zeng, Xinlong Shi, Yani Wang, Yangchun Sun, Lei Wu · 2026 · International Journal of Women s Health
Multi-omics Mendelian randomization prioritizes BMP6 as a candidate therapeutic target in intervertebral disc degeneration
Shunli Kan, Wentao Liu, Peisheng Li, Mengmeng Zhou, Hao Yu, Yuwen Zheng, Wei Hu, Rusen Zhu · 2026 · Journal of Orthopaedic Surgery and Research
Cohort profile: the Mendelian randomisation in pregnancy (MR-PREG) collaboration – improving evidence for prevention and treatment of adverse pregnancy and perinatal outcomes
Nancy McBride, Gemma Clayton, Ana Gonçalves Soares, Qian Yang, Tom A. Bond, Amy E. Taylor, Charikleia Chatzigeorgiou, Elisabeth Aiton, Jane West, Maria C. Magnus et al. · 2026 · BMJ Open
Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets
Han Zhang, Zixian Dang, Pixue Yu, Gui-Hai Chen, Yingze Zhang, Tianrui Wang, Tengbo Yu, Yongtao Zhang, Zhen Shang · 2026 · International Journal of Immunopathology and Pharmacology
Proteogenomic Analysis of Coronary Artery Calcification in Human Populations
Bassim R. El-Sabawi, Xiaoning Huang, Phillip Lin, Mohammad Yaser Anwar, Michael J. Betti, Namju Kim, Andrew Perry, B. Lakshitha A. Perera, Priya Gajjar, Laura Anne Colangelo et al. · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
Challenges and future directions for Mendelian randomization
Eleanor C. M. Sanderson, Michael G. Levin, Venexia M. Walker, Shuai Yuan, Isabella Badini, Julia Dolce, Karina J. Mahida, Ju-Woo Nho, Jean‐Baptiste Pingault, Scott M. Damrauer et al. · 2026 · Nature Genetics
Identification of novel protein biomarkers for knee osteoarthritis by integrating human plasma proteome: evidence from Mendelian randomization and preliminary in vitro investigation
Wang Huang, WeiWei Hu, JiaYu Chen, Dan Yuan · 2026 · Frontiers in Medicine
PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke
Yu-Qian Niu, Zeyu Cai, He Zhi, Yuchun Zhu, Xin-Yuan Xi, Zhen Yang, Dong‐Fu Feng · 2026 · Neurotherapeutics
Multi-omics and machine learning-based exploration of key genes associated with abdominal aortic aneurysm
Ming Xie, Yong Xue, Yufeng Zhang, Lei Zhang, Xiandeng Li, Guobao Chen, Jia Liu, 花海兵 · 2026 · Frontiers in Molecular Biosciences
Identification of PTGS2 as a genetically supported protective biomarker and potential therapeutic target in myasthenia gravis
Yuwei Li, Minxue Zhang, Zhan Liu · 2026 · Journal of Neuroimmunology
Benchmarking Bayesian Colocalization Methods in Validating Mendelian Randomization-identified Targets
Wenmin Zhang, Satoshi Yoshiji, ROBERT M. SLADEK, Josée Dupuis, Tianyuan Lu · 2026 · Genomics Proteomics & Bioinformatics
Proteogenomics in human populations
Ranran Zhai, Anders Mälarstig, Xia Shen · 2026 · Nature Reviews Genetics
Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study
Kevin Y. H. Liang, Thomas M Zheng, Dandan Tan, Takayoshi Sasako, Yann Ilboudo, Yiheng Chen, Guillaume Butler‐Laporte, Satoshi Yoshiji, John Brent Richards · 2026 · PLoS Medicine
Integrated Pleiotropic Gene Set Unveils Comorbidity Insights across Digestive Cancers and Other Diseases
Xinnan Wu, Guangwen Luo, Zhaonian Dong, Wen Zheng, Gengjie Jia · 2024 · Genes
MIMOSA: a resource consisting of improved methylome prediction models increases power to identify DNA methylation-phenotype associations
Hunter J. Melton, Zichen Zhang, Hong‐Wen Deng, Lang Wu, Chong Wu · 2024 · Epigenetics
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Fengyang Wang, Wenpeng Ruan, Qiuyuan Yin, Lei Zhu · 2024 · BMC Pregnancy and Childbirth
Identification of Drug-Targetable Genes for Eczema and Dermatitis Using Integrated Genomic and Proteomic Approaches
Sha Yang, Jianning Song, Min Deng, Si Cheng · 2025 · Dermatitis
Potential drug targets for systemic lupus erythematosus identified through Mendelian randomization analysis
Shiwen Fan, Kaixin Wang, Shuai Wang, Xiangdong Chen · 2025 · Medicine
Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study
Hongwei Zhang, Zixuan Wang, Xiaolong Qiao, Jiaxing Wu, Chuandong Cheng · 2025 · BMC Cancer
Enhancing nonlinear transcriptome- and proteome-wide association studies via trait imputation with applications to Alzheimer’s disease
Ruoyu He, Jingchen Ren, Mykhaylo M. Malakhov, Wei Pan · 2025 · PLoS Genetics
Plasma Circulating Proteins and Intracranial Aneurysm Susceptibility: A Proteome-Wide Mendelian Randomization Analysis
Xuelun Zou, Yishu Tang, Chang Sheng Zhou · 2025 · World Neurosurgery
Decoding aortic dissection from potential drug targets to genetic risk factors: A Mendelian randomization study
Jiaqi Hou, Lihua Lin, Jing Huang, Qianqian Chai, Shujuan Wang, Xiang Liu, Qian Liu · 2025 · European Journal of Pharmacology
Genetically proxied glucagon-like peptide-1 receptor agonist is associated with risk of tubulo-interstitial nephritis: A network Mendelian randomization study
Xuchun Xu, Fangzhong Huang, Jun Ying, Tingting Zhang, Huaying Huang · 2025 · Medicine
Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis
Liangsheng Peng, Huiling Peng, Nuojun Wu, Xiaolong Wang, Han Li, Xinmin Ding · 2025 · Neurosurgical Review
Cross-ethnic Molecular Signatures Underpin the Adverse Impact of Statin Use on Type 2 Diabetes
Fengzhe Xu, Min Yang, Wei Hu, Shuai Yuan, Xue Cai, Wanglong Gou, Zelei Miao, Bangyan Li, Liang Yue, Zhangzhi Xue et al. · 2025 · Genomics Proteomics & Bioinformatics
Multi-ancestry Multivariate Genome-Wide Analysis Highlights the Role of Common Genetic Variation in Cardiac Structure, Function, and Heart Failure-related Traits
Michael G. Levin, Noah L. Tsao, Tiffany R. Bellomo, William P. Bone, Krishna G. Aragam, Yifan Yang, Michael P. Morley, Megan F. Burke, Renae Judy, Zoltan Pierre Arany et al. · 2021 · medRxiv
Immunological pathways underlying autism: Findings from Mendelian randomization and genetic colocalisation analyses
Christina Dardani, Jamie W. Robinson, Jie Zheng, Aws Sadik, Panagiota Pagoni, Evie Stergiakouli, Renee M. Gardner, Alexandra Havdahl, Jakob Grove, the iPSYCH Autism Spectrum Disorder working group et al. · 2022 · medRxiv
Directional anchor genes refine polygenic informed treatment selection in schizophrenia and bipolar disorder
William R. Reay, Michael P. Geaghan, Joshua Ronald Atkins, Vaughan J. Carr, Melissa J. Green, Murray J. Cairns · 2022 · medRxiv
Genetically predicted levels of the human plasma proteome and risk of stroke: a Mendelian Randomization study
Lingyan Chen, James E. Peters, Bram Peter Prins, Elodie Persyn, Matthew Traylor, Praveen Surendran, Savita Karthikeyan, Ekaterina Yonova‐Doing, Emanuele Di Angelantonio, David J. Roberts et al. · 2021 · medRxiv
Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
María Gordillo‐Marañón, Magdalena Zwierzyna, Pimphen Charoen, Fotios Drenos, Sandesh Chopade, Tina Shah, Jorgen Engmann, Juan Pablo Casas, Nish Chaturvedi, Olia Papacosta et al. · 2021 · Research Square
Examining the evidence for Mendelian randomization homogeneity assumption violation using instrument association with exposure variance
Matthew Lyon, Louise A C Millard, George Davey Smith, Fernando Pires Hartwig, Tom R. Gaunt, Kate M. Tilling · 2022 · medRxiv
Editorial: Integrative Approaches to Analyze Cancer Based on Multi‐Omics
Sipeng Shen · 2022 · Frontiers in Genetics
Allergic disease as a causal protective factor for severe covid-19: a multivariable mendelian randomization study
Qianjin Lu, Yangyiyi Yu · 2023
MIMOSA: A resource consisting of improved methylome imputation models increases power to identify DNA methylation-phenotype associations
Hunter J. Melton, Zi-Chen Zhang, Hong-Wen Deng, Lang Wu, Chong Wu · 2023 · medRxiv
The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses
Rosie May Walker, Michael Chong, Nicolas Perrot, Marie Pigeyre, Danni A. Gadd, Aleks Stolicyn, Liu Shi, Archie Campbell, Xueyi Shen, Heather Clare Whalley et al. · 2023 · medRxiv
Tobacco use: a smoking gun for IPF?
Ian P. Hall · 2023 · Thorax
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation
Marion van Vugt, Chris Finan, Sandesh Chopade, Rui Andre Providencia, Connie R. Bezzina, Folkert Wouter Asselbergs, Jessica van Setten, Amand Floriaan Schmidt · 2023 · medRxiv
Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank
Robert Francis Hillary, Danni A. Gadd, Zhana Kuncheva, Tasos Mangelis, Tin-Chi Lin, Kyle L. Ferber, Helen McLaughlin, Heiko Runz, Biogen Biobank Team, Riccardo Emilio Marioni et al. · 2023 · medRxiv
Multiomics-based causal inference identifies novel therapeutic targets for inflammatory bowel disease in East Asians
Jung Oh Kim, Sun Yeop Lee, Eun Gyo Kim, Eunbyeol Lee, Jihye Lee, Yu Jeong Shim · 2023 · Research Square
Prioritization of therapeutic targets for amyotrophic lateral sclerosis using protein-wide Mendelian randomization analysis
Jiawei Geng, Luxi Chen, Chao-Sen Yang, Xixian Ruan, Shixian Hu, Jie Chen, Zhi‐Ying Wu · 2023 · medRxiv
Investigation of the Acute Pathogenesis of Spondyloarthritis/HLA-B27-Associated Anterior Uveitis Based on Genome-Wide Association Analysis and Single Cell Transcriptomics
Shuming Chen, Weidi Huang, Qiaoqian Wan, Zichun Tang, Li Xie, Fang Zeng, Shuyan Zheng, Zhuo Li, Xiao Liu · 2024 · SSRN Electronic Journal
GWAS of ∼30,000 samples with bone mineral density at multiple skeletal sites and its clinical relevance on fracture prediction, genetic correlations and prioritization of drug targets
Yu Qian, Jiangwei Xia, Pingyu Wang, Chao Xie, Hongli Lin, Gloria Hoi‐Yee Li, Cheng‐Da Yuan, Mo-Chang Qiu, Yi-Hu Fang, Chun-Fu Yu et al. · 2024 · medRxiv
A Mendelian randomization study identifies proteins involved in neurodegenerative diseases
Lazaros Belbasis, Sam Morris, Cornelia M. van Duijn, Derrick Bennett, Robin G. Walters · 2024 · medRxiv
Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approaches
Jie Zhang, Xinyu Fang, Jingwei Wu, Zixing Zhang, Min Mu, Dong‐Qing Ye · 2024 · medRxiv
Exploring Potential Drug Targets for Pancreatic Cancer Based on Mendelian Randomization
Peishan Yao, junming huang, yi dang, Ya Wang · 2024 · Research Square
Transcriptome- and proteome-wide Mendelian randomization to prioritize therapeutic targets for coronary heart disease
Liam Gaziano, Elias Allara, Claudia Giambartolomei, David Stacey, Jing Hua Zhao, Hesam Dashti, Tao Jiang, Scott C. Ritchie, Brian R. Ferolito, Danielle Rasooly et al. · 2024 · medRxiv
Phenome-wide causal proteomics enhance systemic lupus erythematosus flare prediction: A study in Asian populations
Liying Chen, Ou Deng, Ting Fang, Mei Chen, Xvfeng Zhang, Ruichen Cong, Dingqi Lu, Runrun Zhang, Qun Jin, Xinchang Wang · 2024 · medRxiv
Genetically predicted plasma erythropoietin levels and clonal haematopoiesis risk: a Mendelian randomisation study
George Richenberg, Paul Carter, Tom R. Gaunt, Siddhartha Kar · 2024 · medRxiv
Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues
Ozvan Bocher, Ana Luiza Arruda, Satoshi Yoshiji, Chi George Zhao, Chen‐Yang Su, Xianyong Yin, Davis Cammann, Henry J. Taylor, Jingchun Chen, Suzuki Ken et al. · 2025 · medRxiv
Phenome-wide Mendelian randomization identifying circulating proteins for cardiovascular traits in populations of African ancestry
Susannah Selber‐Hnatiw, Katerina Trajanoska, Justin Pelletier, Chen‐Yang Su, Peyton McClelland, Daniel Taliun, Satoshi Yoshiji, Vincent Mooser, Claude Bhérer, Sirui Zhou · 2025 · medRxiv
Multi-Tissue Profiling Reveals tissue-specific protein regulation and relationships Between Protein Quantitative Trait Loci (pQTLs) and Cardiometabolic Disease
April E. Hartley, Katyayani Sukhavasi, Sile Hu, Matthew Traylor, Mar González-Ramírez, Kristian Hanghøj, Husain Ahammad Talukdar, Arno Ruusalepp, Ellen Björkegren, Johan Björkegren et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
A foundation model for mapping the phenomic and genetic landscape of cerebral small vessel disease biomarkers
Weikang Gong, Fang Lan, Peng Ren, Hao Hu, Wenjing Su, He‐Ying Hu, Qiong-Yao Li, Xiao‐He Hou, Liang-Yu Huang, Quan Hao et al. · 2025 · medRxiv
Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn’s disease risk
Sidan Wang, Lintao Dan, Xixian Ruan, Judith Wellens, Yuhao Sun, Jialu Yao, Li Tian, Rahul Kalla, Evropi Τheodoratou, Shuai Yuan et al. · 2026 · medRxiv
Pairwise genetic interactions modulate lipid plasma levels and cellular uptake
M. Zimoń, Yunfeng Huang, Anthi Trasta, Jimmy Z. Liu, Chia‐Yen Chen, Aliaksandr A. Halavatyi, Peter Blattmann, Bernd Klaus, Christopher D. Whelan, David Sexton et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Multi-ancestry Genome-wide Association Study of Varicose Veins Reveals Polygenic Architecture, Genetic Overlap with Arterial and Venous Disease, and Novel Therapeutic Opportunities
Michael G. Levin, Jennifer E. Huffman, Anurag Verma, Kyle A. Sullivan, Alexis Rodriguez, David Kainer, Michael R. Garvin, Matthew J. Lane, Hyejung Won, Binglan Li et al. · 2022 · medRxiv
Genetic Control of Body Weight by the Human Brain Proteome
Éloi Gagnon, Arnaud S. Girard, Émilie Gobeil, Jérôme Bourgault, Christian Yves Couture, Patricia L. Mitchell, Claude Bouchard, Angelo Tremblay, Patrick Mathieu, Andréanne Michaud et al. · 2022 · SSRN Electronic Journal
Multi-Ancestry Mendelian Randomization of Omics Traits Revealing Putative Drug Targets of COVID-19 Severity
Jie Zheng, Yuemiao Zhang, Huiling Zhao, Yi Liu, Denis A. Baird, Mohd Anisul Karim, Maya Ghoussaini, Jeremy Schwartzentruber, Ian Dunham, Benjamin Elsworth et al. · 2022 · SSRN Electronic Journal
Proteomic discovery in diabetic kidney disease—to what end?
Eugene P. Rhee · 2022 · Kidney International
Probabilistic integration of transcriptome-wide association studies and colocalization analysis prioritizes molecular pathways of complex traits
Jeffrey Okamoto, Lijia Wang, Xianyong Yin, Francesca Luca, Roger Piqué-Regi, Adam S. Helms, Hae Kyung Im, Jean Morrison, Xiaoquan Wen · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Prioritizing treatments for stroke through human genetics
Derek M. Klarin · 2022 · Nature Cardiovascular Research
Genetically-proxied anti-diabetic drug target perturbation and risk of cancer: a Mendelian randomization analysis
James Yarmolinsky, Emmanouil Bouras, Andrei‐Emil Constantinescu, Kimberley Burrows, Caroline J. Bull, Emma E. Vincent, Richard Michael Martin, Olympia Dimopoulou, Sarah Jane Lewis, Victor Rau Moreno et al. · 2022 · medRxiv
A survey of proteomic variation across two ethnic groups in Nigeria and its relationship to obesity risk
Arjun Biddanda, Karen Perez de Arce, Golibe Eze-Echesi, Chiamaka Nwuba, Yusuf Ibrahim, Olubukunola Oyedele, Esha Joshi, Boladale Ajani Alalade, Olanrewaju Ajayi, Chidimma Brenda Nwatu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Review: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR7
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Review: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR8
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Author comment: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR6
Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Recommendation: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR4
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Recommendation: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR9
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Decision: Mendelian randomization as a tool to inform drug development using human genetics — R1/PR10
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Decision: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR5
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Review: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR2
Iyas Daghlas, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Review: Mendelian randomization as a tool to inform drug development using human genetics — R0/PR3
Iyas Daghlas, Dipender Gill · 2022 · Cambridge Prisms Precision Medicine